Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System.
Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System.
复制标题
DOI：
10.3390/healthcare10020264
复制
发表时间：
2022-01-29
期刊：
影响因子：
--
通讯作者：
Cogle CR
中科院分区：
文献类型：
--
作者：
Kelkar AH;Zhao J;Wang S;Cogle CR
于2019冠状病毒病（COVID-19）大流行的第一年，预防措施包括隔离及关闭设施。由于癌症筛查依赖于设施中的干预措施，因此COVID-19对筛查的影响程度受到质疑。查询了一个大型卫生系统的索赔登记处的结直肠癌和前列腺癌筛查。通过比较2020年筛查与历史参考年计算筛查缺口和筛查损失率。在大流行的前四个月，所有癌症筛查都有所减少。结直肠癌筛查于二零二零年后六个月恢复至基线水平。前列腺癌筛查在后六个月超过基线，但与前几年相比增幅较小。受癌症筛查减少影响的人群包括男性和黑人。为了弥补最初筛查的不足，估计结直肠癌筛查率需要增加50%。
During the first year of the coronavirus disease 2019 (COVID-19) pandemic, prevention measures included quarantining and facility closures. Because cancer screening is dependent on interventions in facilities, the extent of the COVID-19 impact on screening was questioned. A claims registry from a large health system was queried for colorectal and prostate cancer screening. A screening gap and screening loss ratio were calculated by comparing 2020 screening to historical reference years. All cancer screenings decreased in the first four months of the pandemic. Colorectal cancer screening returned to baseline in the latter six months of 2020. Prostate cancer screening exceeded baseline in the latter six months, but with a lesser gain than previous years. Populations disproportionately affected by decreased cancer screening included men and black people. To catch-up after the initial deficit in screening, it is estimated that the rate of colorectal cancer screening needs to increase by 50%.
登录
查看更多内容
影响因子：
5.2
作者：
Dennis LK;Hsu CH;Arrington AK
通讯作者：
Arrington AK
影响因子：
28.4
作者：
Chen, Ronald C.;Haynes, Kevin;Katz, Aaron J.
通讯作者：
Katz, Aaron J.
影响因子：
4.2
作者：
Patt D;Gordan L;Diaz M;Okon T;Grady L;Harmison M;Markward N;Sullivan M;Peng J;Zhou A
通讯作者：
Zhou A
影响因子：
5.1
作者：
Croswell JM;Corley DA;Lafata JE;Haas JS;Inadomi JM;Kamineni A;Ritzwoller DP;Vachani A;Zheng Y;National Cancer Institute Population-based Research to Optimize the Screening Process (PROSPR) II Consortium
通讯作者：
National Cancer Institute Population-based Research to Optimize the Screening Process (PROSPR) II Consortium
影响因子：
2.8
作者：
Cancino RS;Su Z;Mesa R;Tomlinson GE;Wang J
通讯作者：
Wang J